| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |